Replimune Group, Inc. (REPL)
7.15
-0.50
(-6.54%)
USD |
NASDAQ |
Mar 02, 16:00
7.15
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Price : 7.15 for March 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 16.32 |
| Bristol Myers Squibb Co. | 62.32 |
| ACADIA Pharmaceuticals, Inc. | 22.81 |
| Alnylam Pharmaceuticals, Inc. | 324.97 |
| Savara, Inc. | 6.03 |
Price Related Metrics
| PEG Ratio | -0.143 |
| Price to Book Value | 2.804 |
| Earnings Yield | -50.10% |
| Market Cap | 590.39M |
| PEGY Ratio | -0.143 |